STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Sees Large Decrease in Short Interest

STRATA Skin Sciences, Inc. (NASDAQ:SSKN) saw a large decline in short interest in April. As of April 30th, there was short interest totalling 28,000 shares, a decline of 82.2% from the April 15th total of 157,200 shares. Currently, 0.2% of the shares of the company are short sold. Based on an average daily volume of 28,200 shares, the days-to-cover ratio is presently 1.0 days.

STRATA Skin Sciences Trading Down 1.6 %

Shares of SSKN stock traded down $0.01 during trading hours on Friday, reaching $0.38. 18,219 shares of the company’s stock were exchanged, compared to its average volume of 28,748. The company has a debt-to-equity ratio of 1.19, a quick ratio of 1.06 and a current ratio of 1.28. STRATA Skin Sciences has a 1 year low of $0.26 and a 1 year high of $1.10. The company’s 50 day moving average is $0.48 and its two-hundred day moving average is $0.50.

Shares of STRATA Skin Sciences are going to reverse split on Friday, June 7th. The 1-10 reverse split was announced on Friday, June 7th. The number of shares owned by shareholders will be adjusted after the market closes on Friday, June 7th.

STRATA Skin Sciences (NASDAQ:SSKN) last announced its quarterly earnings results on Wednesday, March 27th. The medical device company reported ($0.04) earnings per share (EPS) for the quarter. STRATA Skin Sciences had a negative net margin of 32.47% and a negative return on equity of 52.50%. The company had revenue of $8.69 million during the quarter. Analysts anticipate that STRATA Skin Sciences will post -0.19 earnings per share for the current year.

Institutional Investors Weigh In On STRATA Skin Sciences

A number of hedge funds and other institutional investors have recently modified their holdings of SSKN. Chicago Partners Investment Group LLC increased its stake in STRATA Skin Sciences by 162.0% in the 4th quarter. Chicago Partners Investment Group LLC now owns 64,223 shares of the medical device company’s stock valued at $33,000 after purchasing an additional 39,706 shares in the last quarter. Azzad Asset Management Inc. ADV increased its position in shares of STRATA Skin Sciences by 289.5% in the first quarter. Azzad Asset Management Inc. ADV now owns 67,000 shares of the medical device company’s stock valued at $25,000 after buying an additional 49,800 shares in the last quarter. Finally, 22NW LP raised its stake in shares of STRATA Skin Sciences by 56.1% during the 3rd quarter. 22NW LP now owns 5,369,954 shares of the medical device company’s stock worth $3,195,000 after buying an additional 1,930,693 shares during the last quarter. 32.43% of the stock is currently owned by institutional investors and hedge funds.

STRATA Skin Sciences Company Profile

STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.